Europe Point-of-Care Molecular Diagnostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Point-of-Care Molecular Diagnostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Point-of-Care Molecular Diagnostics Market Regional Analysis

6.2 Europe Point-of-Care Molecular Diagnostics Market Revenue 2019-2028 (US$ Million)

6.3 Europe Point-of-Care Molecular Diagnostics Market Forecast Analysis

7. Europe Point-of-Care Molecular Diagnostics Market Analysis – by Product & Services

7.1 Assays and Kits

7.1.1 Overview
7.1.2 Assays and Kits: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Instruments

7.2.1 Overview
7.2.2 Instruments: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Services and Software

7.3.1 Overview
7.3.2 Services and Software: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Point-of-Care Molecular Diagnostics Market Analysis – by Technology

8.1 PCR

8.1.1 Overview
8.1.2 PCR: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Isothermal Nucleic Acid Amplification Technology

8.2.1 Overview
8.2.2 Isothermal Nucleic Acid Amplification Technology: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.3 Other Technologies

8.3.1 Overview
8.3.2 Other Technologies: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Point-of-Care Molecular Diagnostics Market Analysis – by Application

9.1 Infectious Diseases

9.1.1 Overview
9.1.2 Infectious Diseases: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Oncology

9.2.1 Overview
9.2.2 Oncology: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Hematology

9.3.1 Overview
9.3.2 Hematology: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.4 Prenatal Testing

9.4.1 Overview
9.4.2 Prenatal Testing: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.5 Endocrinology

9.5.1 Overview
9.5.2 Endocrinology: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.6 Other Applications

9.6.1 Overview
9.6.2 Other Applications: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Point-of-Care Molecular Diagnostics Market Analysis – by End User

10.1 Hospitals and Clinics

10.1.1 Overview
10.1.2 Hospitals and Clinics: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.2 Diagnostic Laboratories

10.2.1 Overview
10.2.2 Diagnostic Laboratories: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10.3 Research and Academic Institutes

10.3.1 Overview
10.3.2 Research and Academic Institutes: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. Europe Point-of-Care Molecular Diagnostics Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
11.2.1.1 Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 UK: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
11.2.1.1.2 UK: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
11.2.1.1.3 UK: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Application
11.2.1.1.4 UK: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by End User

11.2.1.2 Germany: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Germany: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
11.2.1.2.2 Germany: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
11.2.1.2.3 Germany: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Application
11.2.1.2.4 Germany: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by End User

11.2.1.3 France: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 France: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
11.2.1.3.2 France: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
11.2.1.3.3 France: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Application
11.2.1.3.4 France: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by End User

11.2.1.4 Russia: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Russia: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
11.2.1.4.2 Russia: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
11.2.1.4.3 Russia: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Application
11.2.1.4.4 Russia: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by End User

11.2.1.5 Italy: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Italy: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
11.2.1.5.2 Italy: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
11.2.1.5.3 Italy: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Application
11.2.1.5.4 Italy: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by End User

11.2.1.6 Rest of Europe: Europe Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
11.2.1.6.2 Rest of Europe: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
11.2.1.6.3 Rest of Europe: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by Application
11.2.1.6.4 Rest of Europe: Europe Point-of-Care Molecular Diagnostics Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 bioMérieux SA

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 F. Hoffmann-La Roche Ltd.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Danaher Corporation

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Enzo Biochem, Inc.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Abbott

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 binx health, Inc.

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 Meridian BioScience, Inc.

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Biocartis

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Quidel Corporation

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Bio-Rad Laboratories, Inc

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Point-of-Care Molecular Diagnostics Market